— Know what they know.
Not Investment Advice

ALKS NASDAQ

Alkermes plc
1W: +0.5% 1M: +10.4% 3M: -8.3% YTD: +56.8% 1Y: +48.7% 3Y: +64.0% 5Y: +42.9%
$44.32
-0.12 (-0.27%)
 
Weekly Expected Move ±4.8%
$39 $42 $44 $46 $48
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Strong Buy · Power 73 · $7.4B mcap · 155M float · 1.33% daily turnover · Short 61% of daily vol
Credit Risk of going bust: lower than 62% of companies Debt: 17.5% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.75 (down 98%), Alkermes plc would be worth roughly what it owes.
Total debt $1.57B against a stock market value of $7.44B.
Distance to default 6.43 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $764.8M (short-term plus half of long-term), stock volatility 40.1%; Altman Z'' 1.67. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

📊 Key Metrics

TTM
$2B
Revenue
+10.8% YoY
$66M
Net Income
-81.0% YoY
$222M
Free Cash Flow
-53.8% YoY
80.2%
Gross Margin
3.7%
Op. Margin
0.1%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE3.9%
ROA2.0%
ROIC2.9%

Valuation

P/E110.1
P/B4.1
EV/EBITDA44.2

Leverage

Debt/Equity0.87
Current Ratio2.30
Interest Cov.2.6x

Quality Scores

Piotroski F4/9
Altman Z2.50
Beneish M-0.83

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms